FDA Grants Full Approval to Sirturo for Treatment of Multi-Drug Resistant Tuberculosis
WASHINGTON, D.C. — The Food and Drug Administration (FDA) has given its full approval to Sirturo (bedaquiline), a drug used in the treatment of pulmonary tuberculosis (TB) that is resistant …
FDA Grants Full Approval to Sirturo for Treatment of Multi-Drug Resistant Tuberculosis Read More